A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

NCT04902027 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Head and Neck Cancer
Metastatic Head and Neck Cancer

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.